Publications by authors named "H-W Pang"

Decades of research have established that mammalian transcription factors (TFs) bind to each gene's regulatory regions and cooperatively control tissue specificity, timing, and intensity of gene transcription. Mapping the combination of TF binding sites genome wide is critically important for understanding functional genomics. Here, we report a technique to measure TFs' binding sites on the human genome with a near single-base resolution by footprinting with deaminase (FOODIE) on a single-molecule and single-cell basis.

View Article and Find Full Text PDF
Article Synopsis
  • - This clinical trial compared the safety and effectiveness of an inhaled COVID-19 vaccine (Ad5-nCoV-IH) against an intramuscular vaccine (BNT-IM) in 540 vaccinated adults in Malaysia from September 2022 to May 2023.
  • - While Ad5-nCoV-IH exhibited lower immunogenicity (with a GMC ratio of 0.22) compared to BNT-IM, it resulted in fewer adverse drug reactions (39.26% vs. 64.68%) and no serious side effects were documented.
  • - Both vaccines demonstrated similar efficacy against COVID-19 variants, but the study concluded that Ad5-nCoV-IH did not meet the non
View Article and Find Full Text PDF

The randomized, multicenter, double-blind, placebo-controlled, phase III PEONY trial (NCT02586025) demonstrated significantly improved total pathologic complete response (primary endpoint) with dual HER2 blockade in HER2-positive early/locally advanced breast cancer, as previously reported. Here, we present the final, long-term efficacy (secondary endpoints: event-free survival, disease-free survival, overall survival) and safety analysis (62.9 months' median follow-up).

View Article and Find Full Text PDF

Background: Previous EWASs (Epigenome-Wide Association Studies) have reported hundreds of blood pressure (BP) associated 5'-cytosine-phosphate-guanine-3' (CpG) sites. However, their results were inconsistent. Longitudinal observations on the temporal relationship between DNA methylation and BP are lacking.

View Article and Find Full Text PDF
Article Synopsis
  • - Understanding who might experience severe COVID-19 is crucial for effective treatment decisions in clinical settings, as demonstrated in the COMET-ICE clinical trial which tested the monoclonal antibody sotrovimab against a placebo.
  • - Key laboratory indicators of severe disease risk include a high neutrophil-to-lymphocyte ratio (NLR), low SARS-CoV-2 antibodies, and specific whole-blood gene expression profiles, with the latter being particularly predictive of hospitalization or death.
  • - Treatment with sotrovimab not only stabilizes these risk factors like NLR but also reduces viral levels in the body, and a newly identified 10-gene signature can help quickly assess patients at risk for severe outcomes.
View Article and Find Full Text PDF

Background And Objectives: Contemporary cardiovascular disease (CVD) risk prediction models are rarely applied in routine clinical practice in China due to substantial regional differences in absolute risks of major CVD types within China. Moreover, the inclusion of blood lipids in most risk prediction models also limits their use in the Chinese population. We developed 10-year CVD risk prediction models excluding blood lipids that may be applicable to diverse regions of China.

View Article and Find Full Text PDF

Genomic structural variants comprise a significant fraction of somatic mutations driving cancer onset and progression. However, such variants are not readily revealed by standard next-generation sequencing. Optical genome mapping (OGM) surpasses short-read sequencing in detecting large (>500 bp) and complex structural variants (SVs) but requires isolation of ultra-high-molecular-weight DNA from the tissue of interest.

View Article and Find Full Text PDF

Serological tests play an essential role in monitoring and combating the COVID-19 pandemic. Recombinant spike protein (S protein), especially the S1 protein, is one of the major reagents used for serological tests. However, the high cost of S protein production and possible cross-reactivity with other human coronaviruses pose unavoidable challenges.

View Article and Find Full Text PDF

Background Accurate clinical staging is crucial to managing gastrointestinal cancer, but fluorine 18 (F) fluorodeoxyglucose (FDG) PET/CT has limitations. Targeting fibroblast-activation protein is a newer diagnostic approach for the visualization of tumor stroma, and gallium 68 (Ga)-labeled fibroblast-activation protein inhibitors (FAPIs), hereafter Ga-FAPIs, present a promising alternative to F-FDG. Purpose To compare the diagnostic efficacy of Ga-FAPI PET/CT in primary and metastatic lesions of gastrointestinal malignancies with that of F-FDG PET/CT.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to explore how a specific mutation in the HIF-2α protein affects brain and spine development in patients with gain-of-function syndrome, which is linked to conditions like paragangliomas and polycythemia.
  • Eight patients were evaluated, revealing that all had malformations in the posterior fossa, mostly Chiari malformations, while many also experienced spinal dysraphism and vertebral segmentation issues.
  • Findings from transgenic mouse models mirrored human symptoms, showcasing similar spinal malformations and suggesting that the mutation leads to incomplete mesenchymal transition, potentially affecting normal development.
View Article and Find Full Text PDF

The solar selective absorber coating (SSAC) are at the core of the efficient solar-thermal system. In this paper, for the first time, the Chromium-iron oxidation mixture cermet was successfully prepared on the surface of ultra-pure ferritic stainless steel by chemical coloring as SSAC. The coating surface has an optical trap structure, and the chromium-iron oxidation mixture cermet is used as an absorption layer to realize solar-thermal conversion.

View Article and Find Full Text PDF

Aim: To determine the safety of a higher starting dose of basal insulin in overweight/obese patients with type 2 diabetes (T2D).

Materials And Methods: This 16-week, randomized, multicentre, open-label trial enrolled adults with T2D (body mass index 25-40 kg/m ) and suboptimal glycaemic control (glycated haemoglobin [HbA1c] 7.5-11.

View Article and Find Full Text PDF

Polyelectrolyte complex (PEC) nanoparticles assembled from plasmid DNA (DNA) and polycations such as linear polyethylenimine (PEI) represent a major nonviral delivery vehicle for gene therapy tested thus far. Efforts to control the size, shape, and surface properties of DNA/polycation nanoparticles have been primarily focused on fine-tuning the molecular structures of the polycationic carriers and on assembly conditions such as medium polarity, pH, and temperature. However, reproducible production of these nanoparticles hinges on the ability to control the assembly kinetics, given the nonequilibrium nature of the assembly process and nanoparticle composition.

View Article and Find Full Text PDF

Benzbromarone (BBR) is effective in the treatment of gout; however, clinical findings have shown it can also cause fatal hepatic failure. Our early studies demonstrated that CYP3A catalyzed the biotransformation of BBR to epoxide intermediate(s) that reacted with sulfur nucleophiles of protein to form protein covalent binding both in vitro and in vivo. The present study attempted to define the correlation between metabolic epoxidation and hepatotoxicity of BBR by manipulating the structure of BBR.

View Article and Find Full Text PDF

Background: Reduced fat oxidation in hypertrophied hearts coincides with a shift of carnitine palmitoyl transferase I from muscle to increased liver isoforms. Acutely increased carnitine palmitoyl transferase I in normal rodent hearts has been shown to recapitulate the reduced fat oxidation and elevated atrial natriuretic peptide message of cardiac hypertrophy.

Methods And Results: Because of the potential for reduced fat oxidation to affect cardiac atrial natriuretic peptide, and thus, induce adipose lipolysis, we studied peripheral and systemic metabolism in male C57BL/6 mice model of transverse aortic constriction in which left ventricular hypertrophy occurred by 2 weeks without functional decline until 16 weeks (ejection fraction, -45.

View Article and Find Full Text PDF

Background: There are no reports on a large-scale randomized trial exploring optimal dual antiplatelet therapy (DAPT) duration after biodegradable polymer sirolimus-eluting stent implantation. We sought to report the outcomes of a randomized substudy of the prospective Evaluate Safety and Effectiveness of the Tivoli DES and the Firebird DES for Treatment of Coronary Revascularization (I-LOVE-IT 2) trial.

Methods And Results: In the prospective noninferiority randomized I-LOVE-IT 2 trial, 1829 patients allocated to the biodegradable polymer sirolimus-eluting stent group were also randomized to receive either 6-month (n=909) or 12-month DAPT (n=920).

View Article and Find Full Text PDF

The biochemical and toxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) have been the subject of intense study for decades. It is now clear that essentially all TCDD-induced toxicities are mediated by DNA-protein interactions involving the Aryl Hydrocarbon Receptor (AHR). Nevertheless, it remains unknown which AHR target genes cause TCDD toxicities.

View Article and Find Full Text PDF